Synthetic biology startup Asimov snaps $200M to address major flaw in drug manufacturing

Retrieved on: 2023-01-06 07:30:57

Tags for this article:

Click the tags to see associated articles and topics

Synthetic biology startup Asimov snaps $200M to address major flaw in drug manufacturing. View article details on hiswai:

Excerpt

US-based synthetic biology startup, Asimov which develops tools to design living systems, snapped $200 million in new funding.

Article found on: techfundingnews.com